Associated Papers
Risk stratification for RYR2-mediated catecholaminergic polymorphic ventricular tachycardia: time to broaden the lens.
Young WJ et al.
European Heart Journal, 2026
Pharmacogenomics and chronotherapy of drug-induced cardioprotection in acute myocardial infarction.
Clemente-Moragón A et al.
Nature Communications, 2025
Investigating ADRB1 and ADRB3 polymorphisms as risk factors for type 2 diabetes: A retrospective study.
Abd Al-Hameed AW et al.
Gene, 2025
Clinical medication guidance for hypertension personalization through pharmacogenomic research and analysis.
Ren Q et al.
Global Medical Genetics, 2025
Pharmacogenomics in cardiac therapy: Personalizing treatment for heart health.
Naderi N et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 2025
The pharmacogenomic landscape in the Chinese: An analytics of pharmacogenetic variants in 206,640 individuals.
Wang LY et al.
Innovation (cambridge (mass.)), 2025
Deciphering the Role of Calcium Signaling Pathway-Associated Single Nucleotide Variants in Susceptibility to Hypertension.
Sharifi A et al.
Journal of Clinical Laboratory Analysis, 2025
Computational analysis of congenital heart disease associated SNPs: unveiling their impact on the gene regulatory system.
Vashisht S et al.
Bmc Genomics, 2025
Genetics and Pharmacogenetics of Atrial Fibrillation: A Mechanistic Perspective.
Owais A et al.
Jacc. Basic to Translational Science, 2024
Genetic Variation in ABCB1, ADRB1, CYP3A4, CYP3A5, NEDD4L and NR3C2 Confers Differential Susceptibility to Resistant Hypertension among South Africans.
Katsukunya JN et al.
Journal of Personalized Medicine, 2024
Impact of CYP2D6 and ADRB1 polymorphisms on heart rate of post-PCI patients treated with metoprolol.
Gao X et al.
Pharmacogenomics, 2024
Structural and Functional Impact of Adrenoceptor Beta-1 Gene Polymorphism in Patients with Hypertrophic Cardiomyopathy and Response to Beta-Blocker Therapy.
Raimoglou D et al.
Anatolian Journal of Cardiology, 2024
Association of Antihypertensive Drug-Related Gene Polymorphisms with Stroke in the Chinese Hypertensive Population.
Liu H et al.
International Journal of Hypertension, 2024
Genetic polymorphisms in ADRB1, ADRB2 and CYP2D6 genes and response to beta-blockers in patients with acute coronary syndrome.
Castaño-Amores C et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 2023
Associations between Selected ADRB1 and CYP2D6 Gene Polymorphisms in Children with Ventricular and Supraventricular Arrhythmias.
Moric-Janiszewska E et al.
Medicina (kaunas, Lithuania), 2023
Base-Excision Repair Mutational Signature in Two Sebaceous Carcinomas of the Eyelid.
Sangiorgi E et al.
Genes, 2023
Functional mutation, splice, distribution, and divergence analysis of impactful genes associated with heart failure and other cardiovascular diseases.
Mhatre I et al.
Scientific Reports, 2023
Effect of β1-adrenergic receptor gene polymorphism on ventricular arrhythmia and prognosis after myocardial infarction.
Ran T et al.
Coronary Artery Disease, 2023
Is it time for genetic modifiers to predict prognosis in Duchenne muscular dystrophy?
Bello L et al.
Nature Reviews. Neurology, 2023
Genetic and phenotypic frequency distribution of ACE, ADRB1, AGTR1, CYP2C9*3, CYP2D6*10, CYP3A5*3, NPPA and factors associated with hypertension in Chinese Han hypertensive patients.
Wang Z et al.
Medicine, 2023
Screening and validation of double allele-specific binding F-primers for the measurement of antihypertensive pharmacogenomics.
Ping Y et al.
Frontiers in Medicine, 2023
Association between MTHFR C677T polymorphism and risk of coronary artery disease in the Chinese population: meta-analysis.
Li L et al.
Herz, 2022
Expanding the prostate cancer cell line repertoire with ACRJ-PC28, an AR-negative neuroendocrine cell line derived from an African-Caribbean patient.
Valentine H et al.
Cancer Research Communications, 2022
Personalized antihypertensive treatment guided by pharmacogenomics in China.
Xiao ZL et al.
Cardiovascular Diagnosis and Therapy, 2022
Vasovagal Syncope Is Associated with Variants in Genes Involved in Neurohumoral Signaling Pathways.
Titov B et al.
Genes, 2022
Pharmacogenetics may explain part of the interindividual variability of dobutamine pharmacodynamics in neonates.
Hallik M et al.
British Journal of Clinical Pharmacology, 2022
Genetic polymorphisms in ADRB2 and ADRB1 are associated with differential survival in heart failure patients taking β-blockers.
Guerra LA et al.
The Pharmacogenomics Journal, 2022
Lack of Effects of Renin-Angiotensin-Aldosterone System Activity and Beta-Adrenoceptor Pathway Polymorphisms on the Response to Bisoprolol in Hypertension.
Zeng W et al.
Frontiers in Cardiovascular Medicine, 2022
Investigating changes in β-adrenergic gene expression (ADRB1 and ADRB2) in Takotsubo (stress) cardiomyopathy syndrome; a pilot study.
Tutgun Onrat S et al.
Molecular Biology Reports, 2021
Decoding variants in drug-metabolizing enzymes and transporters in solid tumor patients by whole-exome sequencing.
Aboul-Soud MAM et al.
Saudi Journal of Biological Sciences, 2021
Whole-Exome Sequencing in Patients Affected by Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Reveals New Variants Potentially Contributing to the Phenotype.
Fonseca DJ et al.
Pharmacogenomics and Personalized Medicine, 2021
Association Study of the Beta-Adrenergic Receptor Genetic Variant Gly389Arg and Fluoxetine Response in Major Depression.
Firouzabadi N et al.
Galen Medical Journal, 2020
[The role of ADRB1 genes polymorphism in examined patients with chronic rheumatic heart disease].
Petrov VS et al.
Problemy Sotsial'noi Gigieny, Zdravookhraneniia I Istorii Meditsiny, 2019
Introducing the first whole genomes of nationals from the United Arab Emirates.
AlSafar HS et al.
Scientific Reports, 2019
Distinctive mutational spectrum and karyotype disruption in long-term cisplatin-treated urothelial carcinoma cell lines.
Skowron MA et al.
Scientific Reports, 2019
[POLYMORPHISM OF THE BETA1- AND BETA2-ADRENORECEPTOR GENES AND BISOPROLOL EFFICIENCY IN PATIENTS WITH HEART FAILURE].
Pyvovar S et al.
Georgian Medical News, 2019
Targeted next generation sequencing as a tool for precision medicine.
Gulilat M et al.
Bmc Medical Genomics, 2019
Genetic analysis of pharmacogenomic VIP variants in the Blang population from Yunnan Province of China.
Zhang C et al.
Molecular Genetics & Genomic Medicine, 2019
Genetic Association Study in Multigenerational Kindreds With Vasovagal Syncope: Evidence for Involvement of Sex-Specific Serotonin Signaling.
Sheldon R et al.
Circulation. Arrhythmia and Electrophysiology, 2019
POLYMORPHISMS IN β-ADRENERGIC RECEPTORS ARE ASSOCIATED WITH INCREASED RISK TO HAVE A POSITIVE HEAD-UP TILT TABLE TEST IN PATIENTS WITH VASOVAGAL SYNCOPE.
Márquez MF et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion, 2019
mRNA expression profile in peripheral blood mononuclear cells based on ADRB1 Ser49Gly and Arg389Gly polymorphisms in essential hypertension - a case-control pilot investigation in South Indian population.
Varakantham V et al.
Clinical Chemistry and Laboratory Medicine, 2018
Mutation analysis of adenomas and carcinomas of the colon: Early and late drivers.
Wolff RK et al.
Genes, Chromosomes & Cancer, 2018
ADRB3 polymorphism rs4994 (Trp64Arg) associates significantly with bodyweight elevation and dyslipidaemias in Saudis but not rs1801253 (Arg389Gly) polymorphism in ARDB1.
Daghestani M et al.
Lipids in Health and Disease, 2018
Polymorphisms in adrenergic receptor genes in Qinchuan cattle show associations with selected carcass traits.
Mei CG et al.
Meat Science, 2018
Beta 1, Beta 2 and Beta 3 Adrenergic Receptor Gene Polymorphisms in a Southeastern European Population.
Katsarou MS et al.
Frontiers in Genetics, 2018